The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
Filters: Collection: ehsl_novel_nam
1 - 25 of 3
| Title | Creator | Description | Identifier | ||
|---|---|---|---|---|---|
| 1 |
 |
Prevention and Treatment of Cerebrovascular Disease | Renee B. Van Stavern | Intravenous thrombolysis with alteplase (Genentech; San Francisco, CA) is the only FDA approved treatment for acute ischemic stroke when administered fewer than 3 hours after the onset of symptoms. The European Cooperative Acute Stroke Study-III (ECASS III) investigators tested the efficacy and safe... | 20130211_nanos_journalclubsympos_04 |
| 2 |
 |
Prevention and Treatment of Cerebrovascular Disease | Renee B. Van Stavern | Intravenous thrombolysis with alteplase (Genentech; San Francisco, CA) is the only FDA approved treatment for acute ischemic stroke when administered fewer than 3 hours after the onset of symptoms. The European Cooperative Acute Stroke Study-III (ECASS III) investigators tested the efficacy and safe... | 20130211_nanos_journalclubsympos_04-2 |
| 3 |
 |
Prevention and Treatment of Cerebrovascular Disease | Renee B. Van Stavern | Intravenous thrombolysis with alteplase (Genentech; San Francisco, CA) is the only FDA approved treatment for acute ischemic stroke when administered fewer than 3 hours after the onset of symptoms. The European Cooperative Acute Stroke Study-III (ECASS III) investigators tested the efficacy and safe... | 20130211_nanos_journalclubsympos_04-1 |
1 - 25 of 3